Rodney Anderson, MD | |
379 North 500 West, Suite 1a, Vernal, UT 84078 | |
(435) 789-1165 | |
(435) 789-1169 |
Full Name | Rodney Anderson |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 35 Years |
Location | 379 North 500 West, Vernal, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952495582 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 91184302-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Canyon Home Care | Salt lake city, UT | Home health agency |
Uintah Basin Medical Center | Roosevelt, UT | Hospital |
Ashley Regional Medical Center | Vernal, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeastern Utah Medical Group | 2961496609 | 45 |
News Archive
NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.
› Verified 1 days ago
Entity Name | Northeastern Utah Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982664199 PECOS PAC ID: 2961496609 Enrollment ID: O20040414000471 |
News Archive
NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Rodney Anderson, MD 379 North 500 West, Suite 1a, Vernal, UT 84078 Ph: (435) 789-1165 | Rodney Anderson, MD 379 North 500 West, Suite 1a, Vernal, UT 84078 Ph: (435) 789-1165 |
News Archive
NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.
› Verified 1 days ago
Dr. Alma L Parker Ii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 N 100 W, Suite 205, Vernal, UT 84078 Phone: 435-781-6300 Fax: 435-781-6301 | |
Hilary J. Sarhatt, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 151 W 200 N, Vernal, UT 84078 Phone: 435-789-3342 | |
Shaun C Shurtliff, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 872 W Highway 40, Vernal, UT 84078 Phone: 435-781-8899 Fax: 435-781-8898 | |
Michael Olsen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 379 North 500 West, Suite 1a, Vernal, UT 84078 Phone: 435-789-1165 Fax: 435-789-1169 | |
Dr. Matthew C Bowen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 N 100 W, Suite 205a, Vernal, UT 84078 Phone: 435-781-1200 Fax: 435-781-1230 | |
Karl Breitenbach, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 379 North 500 West, Suite 1a, Vernal, UT 84078 Phone: 435-789-1165 Fax: 435-789-1169 | |
Bruce A Daniel, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 151 W 200 N, Vernal, UT 84078 Phone: 435-789-3342 |